In Reply: Although the two drugs were not compared head to head, the data from randomized trials suggest that they have similar effects on the amelioration of lower urinary tract symptoms due to benign prostatic hypertrophy. The full results of the REDUCE trial are not yet available and until they are published it is not possible to comment any further on whether one or the other is the better choice for prevention of prostate cancer.
Letters To The Editor
In reply: Prostate cancer prevention
Cleveland Clinic Journal of Medicine. 2009 November;76(11):630
Eric A. Klein, MD
Medical Grand Rounds
- Eric A. Klein, MD
Two large trials of screening with prostate-specific antigen measurements came to seemingly opposite conclusions. Furthermore, a large trial of...